Table 4.
Assay results
|
DST
|
|
---|---|---|
Hain | Resistant | Sensitive |
INH resistant | 26 | 0 |
INH sensitive | 6 | 90 |
Hain INH sensitivity −81.3% (26/32) [95% CI 63.6%–92.8%] | ||
Hain INH specificity −100% (90/90) [95% CI 96.0%–100.0%] | ||
Hain INH PPV −100.0% (26/26) [95% CI 86.8%–100.0%] | ||
Hain INH NPV −93.8% (90/96) [95% CI 86.9%–97.7%] | ||
RT MTB RIF/INH | Resistant | Sensitive |
INH resistant | 28 | 5 |
INH sensitive | 4 | 85 |
RT MTB RIF/INH INH sensitivity −87.5% (28/32) [95% CI 71.0%–96.5%] | ||
RT MTB RIF/INH INH specificity −94.4% (85/90) [95% CI 87.5%–98.2%] | ||
RT MTB RIF/INH INH PPV −84.8% (28/33) [95% CI 68.1%–94.9%] | ||
RT MTB RIF/INH INH NPV −95.5% (85/89) [95% CI 88.9%–98.8%] |
Abbreviations: RT MTB RIF/INH, RealTime MTB RIF/INH Resistance Assay; MTB, Mycobacterium tuberculosis; RIF, rifampicin; INH, isoniazid; DST, drug sensitivity testing; PPV, positive predictive value; NPV, negative predictive value.